vs

Side-by-side financial comparison of Matson, Inc. (MATX) and Pediatrix Medical Group, Inc. (MD). Click either name above to swap in a different company.

Matson, Inc. is the larger business by last-quarter revenue ($851.9M vs $493.8M, roughly 1.7× Pediatrix Medical Group, Inc.). Matson, Inc. runs the higher net margin — 16.8% vs 6.8%, a 10.0% gap on every dollar of revenue. On growth, Pediatrix Medical Group, Inc. posted the faster year-over-year revenue change (-1.7% vs -4.3%). Over the past eight quarters, Matson, Inc.'s revenue compounded faster (8.6% CAGR vs -0.1%).

Matson, Inc., is an American shipping and navigation services company headquartered in Honolulu, Hawaii. Founded in 1882, Matson, Inc.'s subsidiary Matson Navigation Company provides ocean shipping services across the Pacific to Hawaii, Alaska, Guam, Micronesia, the Pacific islands, China, and Japan.

Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.

MATX vs MD — Head-to-Head

Bigger by revenue
MATX
MATX
1.7× larger
MATX
$851.9M
$493.8M
MD
Growing faster (revenue YoY)
MD
MD
+2.6% gap
MD
-1.7%
-4.3%
MATX
Higher net margin
MATX
MATX
10.0% more per $
MATX
16.8%
6.8%
MD
Faster 2-yr revenue CAGR
MATX
MATX
Annualised
MATX
8.6%
-0.1%
MD

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
MATX
MATX
MD
MD
Revenue
$851.9M
$493.8M
Net Profit
$143.1M
$33.7M
Gross Margin
Operating Margin
16.9%
9.9%
Net Margin
16.8%
6.8%
Revenue YoY
-4.3%
-1.7%
Net Profit YoY
11.8%
10.5%
EPS (diluted)
$4.47
$0.40

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MATX
MATX
MD
MD
Q4 25
$851.9M
$493.8M
Q3 25
$880.1M
$492.9M
Q2 25
$830.5M
$468.8M
Q1 25
$782.0M
$458.4M
Q4 24
$890.3M
$502.4M
Q3 24
$962.0M
$511.2M
Q2 24
$847.4M
$504.3M
Q1 24
$722.1M
$495.1M
Net Profit
MATX
MATX
MD
MD
Q4 25
$143.1M
$33.7M
Q3 25
$134.7M
$71.7M
Q2 25
$94.7M
$39.3M
Q1 25
$72.3M
$20.7M
Q4 24
$128.0M
$30.5M
Q3 24
$199.1M
$19.4M
Q2 24
$113.2M
$-153.0M
Q1 24
$36.1M
$4.0M
Operating Margin
MATX
MATX
MD
MD
Q4 25
16.9%
9.9%
Q3 25
18.3%
13.8%
Q2 25
13.6%
12.8%
Q1 25
10.5%
7.0%
Q4 24
16.6%
7.8%
Q3 24
25.2%
6.6%
Q2 24
14.7%
-31.3%
Q1 24
5.1%
3.2%
Net Margin
MATX
MATX
MD
MD
Q4 25
16.8%
6.8%
Q3 25
15.3%
14.5%
Q2 25
11.4%
8.4%
Q1 25
9.2%
4.5%
Q4 24
14.4%
6.1%
Q3 24
20.7%
3.8%
Q2 24
13.4%
-30.3%
Q1 24
5.0%
0.8%
EPS (diluted)
MATX
MATX
MD
MD
Q4 25
$4.47
$0.40
Q3 25
$4.24
$0.84
Q2 25
$2.92
$0.46
Q1 25
$2.18
$0.24
Q4 24
$3.69
$0.37
Q3 24
$5.89
$0.23
Q2 24
$3.31
$-1.84
Q1 24
$1.04
$0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MATX
MATX
MD
MD
Cash + ST InvestmentsLiquidity on hand
$141.9M
$375.2M
Total DebtLower is stronger
$361.2M
$570.5M
Stockholders' EquityBook value
$2.8B
$865.9M
Total Assets
$4.6B
$2.2B
Debt / EquityLower = less leverage
0.13×
0.66×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MATX
MATX
MD
MD
Q4 25
$141.9M
$375.2M
Q3 25
$92.7M
$340.1M
Q2 25
$59.1M
$224.7M
Q1 25
$122.0M
$99.0M
Q4 24
$266.8M
$229.9M
Q3 24
$270.3M
$103.8M
Q2 24
$168.2M
$19.4M
Q1 24
$25.9M
$8.0M
Total Debt
MATX
MATX
MD
MD
Q4 25
$361.2M
$570.5M
Q3 25
$370.9M
$577.2M
Q2 25
$341.3M
$583.9M
Q1 25
$351.1M
$590.5M
Q4 24
$361.2M
$597.1M
Q3 24
$370.9M
Q2 24
$381.0M
Q1 24
$390.8M
Stockholders' Equity
MATX
MATX
MD
MD
Q4 25
$2.8B
$865.9M
Q3 25
$2.7B
$890.7M
Q2 25
$2.6B
$833.8M
Q1 25
$2.6B
$789.2M
Q4 24
$2.7B
$764.9M
Q3 24
$2.6B
$732.5M
Q2 24
$2.4B
$706.5M
Q1 24
$2.4B
$856.2M
Total Assets
MATX
MATX
MD
MD
Q4 25
$4.6B
$2.2B
Q3 25
$4.6B
$2.2B
Q2 25
$4.5B
$2.1B
Q1 25
$4.5B
$2.0B
Q4 24
$4.6B
$2.2B
Q3 24
$4.4B
$2.1B
Q2 24
$4.3B
$2.0B
Q1 24
$4.2B
$2.2B
Debt / Equity
MATX
MATX
MD
MD
Q4 25
0.13×
0.66×
Q3 25
0.14×
0.65×
Q2 25
0.13×
0.70×
Q1 25
0.13×
0.75×
Q4 24
0.14×
0.78×
Q3 24
0.15×
Q2 24
0.16×
Q1 24
0.16×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MATX
MATX
MD
MD
Operating Cash FlowLast quarter
$176.9M
$114.1M
Free Cash FlowOCF − Capex
$42.2M
FCF MarginFCF / Revenue
5.0%
Capex IntensityCapex / Revenue
15.8%
Cash ConversionOCF / Net Profit
1.24×
3.39×
TTM Free Cash FlowTrailing 4 quarters
$153.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MATX
MATX
MD
MD
Q4 25
$176.9M
$114.1M
Q3 25
$175.6M
$137.3M
Q2 25
$105.6M
$137.2M
Q1 25
$89.0M
$-117.5M
Q4 24
$174.7M
$133.0M
Q3 24
$248.6M
$91.8M
Q2 24
$307.9M
$107.0M
Q1 24
$36.6M
$-125.2M
Free Cash Flow
MATX
MATX
MD
MD
Q4 25
$42.2M
Q3 25
$92.4M
Q2 25
$19.3M
Q1 25
$-200.0K
Q4 24
$49.3M
Q3 24
$189.0M
Q2 24
$238.1M
Q1 24
$-18.7M
FCF Margin
MATX
MATX
MD
MD
Q4 25
5.0%
Q3 25
10.5%
Q2 25
2.3%
Q1 25
-0.0%
Q4 24
5.5%
Q3 24
19.6%
Q2 24
28.1%
Q1 24
-2.6%
Capex Intensity
MATX
MATX
MD
MD
Q4 25
15.8%
Q3 25
9.5%
Q2 25
10.4%
Q1 25
11.4%
Q4 24
14.1%
Q3 24
6.2%
Q2 24
8.2%
Q1 24
7.7%
Cash Conversion
MATX
MATX
MD
MD
Q4 25
1.24×
3.39×
Q3 25
1.30×
1.91×
Q2 25
1.12×
3.49×
Q1 25
1.23×
-5.66×
Q4 24
1.36×
4.36×
Q3 24
1.25×
4.72×
Q2 24
2.72×
Q1 24
1.01×
-31.03×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

MATX
MATX

Ocean Transportation Segment$704.2M83%
Logistics Services Segment$147.7M17%

MD
MD

Health Care Patient Service$421.6M85%
Hospitals Contracts$70.0M14%
Other$2.2M0%

Related Comparisons